Allspring Global Investments Holdings, LLC Exelixis, Inc. Transaction History
Allspring Global Investments Holdings, LLC
- $59.3 Billion
- Q4 2024
A detailed history of Allspring Global Investments Holdings, LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 1,562,790 shares of EXEL stock, worth $51.4 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
1,562,790
Previous 858,004
82.14%
Holding current value
$51.4 Million
Previous $22.3 Million
133.73%
% of portfolio
0.09%
Previous 0.04%
Shares
13 transactions
Others Institutions Holding EXEL
# of Institutions
521Shares Held
244MCall Options Held
2.84MPut Options Held
2.29M-
Black Rock Inc. New York, NY33.5MShares$1.1 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.3MShares$964 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA25.4MShares$835 Million3.31% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.4MShares$505 Million0.63% of portfolio
-
State Street Corp Boston, MA11.4MShares$376 Million0.01% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $10.6B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...